Search
Coauthors
Shannon Rivera Department of Chemistry, Emory University, USA
1 protocol

Emily Weinert Department of Chemistry, Emory University, USA
1 protocol

Anil Mehta Department of Chemistry, Emory University, USA
1 protocol

Stefan Kaluz Laboratory of Molecular Neuro-Oncology, Departments of Neurosurgery and Hematology & Medical Oncology, School of Medicine and Winship Cancer Institute, Emory University, USA
1 protocol

Erwin G. Van Meir
  • School of Medicine and Winship Cancer Institute, USA
  • 2 Author merit

Education

Ph.D. in Molecular Virology, University of Lausanne, Switzerland, 1989

Current position

Director, Laboratory of Molecular Neuro-Oncology, Emory University (1998-present)
Professor with Tenure, Neurosurgery and Hematology/Oncology Depts, Emory University (2001-present)
Leader, Winship Cancer Institute Cancer Cell Biology Program (2008-presnet)
Founding Director, Emory Graduate Program in Cancer Biology (2010-present)

Publications

Complete list of published work (>159 total; H-index: 68):
Please do a Pubmed search under “van meir e” or access my google scholar profile:
(Note that I am co-senior author on several team science publications since 2012):
http://scholar.google.com/citations?user=zulNnq0AAAAJ&hl=en

2 Protocols published
Purifying Properly Folded Cysteine-rich, Zinc Finger Containing Recombinant Proteins for Structural Drug Targeting Studies: the CH1 Domain of p300 as a Case Example
Authors:  Yong Joon Kim, Stefan Kaluz, Anil Mehta, Emily Weinert, Shannon Rivera and Erwin G. Van Meir, date: 09/05/2017, view: 864, Q&A: 0
The transcription factor Hypoxia-Inducible Factor (HIF) complexes with the coactivator p300, activating the hypoxia response pathway and allowing tumors to grow. The CH1 and CAD domains of each respective protein form the interface between p300 and ...
Preparation of Recombinant Galectin-3 for Cancer Studies
Authors:  Kari Tyler, Sok-Hyong Lee and Erwin G. Van Meir, date: 01/05/2016, view: 2892, Q&A: 0
Galectin-3 is a member of a class of proteins termed Galectins, characterized by their ability to bind glycans containing β-galactose (Cummings and Liu, 2009). Galectin-3 binds preferentially to proteoglycans terminating with N-acetyllactosamine ...